Decoding Influenza: Analyzing Drug Resistance Patterns in Neuraminidase Genes to Combat Antiviral Ineffectiveness
JSHS · 2025
Overview
The increasing prevalence of antiviral drug resistance in influenza viruses poses a significant threat to public health. Neuraminidase inhibitors, such as Oseltamivir, are widely used to treat influenza, but their effectiveness has diminished due to resist ance-conferring mutations in the neuraminidase (NA) gene. This study aims to identify key mutations linked to resistance and analyze their impact on antiviral sensitivity. It was hypothesized that influenza viruses exhibit distinct drug resistance patterns , with specific NA mutations being more prevalent in resistant strains. Influenza A (H1N1, H3N2) and influenza Bvirus strains from the 2020 –2021 and 2022 –2023 seasons were selected for analysis using the NCBI GenBank database. Neuraminidase protein sequences were aligned with reference sequences using Clustal Omega to detect resistance- associated mutations. Mutations such as H275Y and D197N, previously linked to reduced susceptibility to Oseltamivir, were examined. Resistance levels were categorized based on IC50 values obtained from literature reviews. Higher IC50 values, indicating reduced susceptibility to neuraminidase inhibitors, were correlated with specific mutations. The H275Y mutation, in particular, was associated with significant Oseltamivir resistance. The findings support the hypothesis that certain mutations have a major impact on antiviral susceptibility and occur more frequently in resistant strains. This study highlights the importance of continuous surveillance of resistance-conferring mutations to inform antiviral treatment strategies and public health initiatives. Understanding resistance patterns can aid in the development of more effective antivi ral drugs and vaccines, ultimately improving the management of future influenza outbreaks.
Competition history
- JSHS 2025
Resources
Related projects
ISEF · 2014
Towards a Combination Antiviral Therapy for Flu: An Interdisciplinary Drug Discovery Effort
ISEF · 2021
CRISPR Cas9 as a Possible Mechanism to Modify Influenza Viral Mutation
ISEF · 2024
Evolving an Epidemic: Optimizing Sialic Acid Receptor Configurations to Increase the Binding Affinity of Avian Influenza H5N1 to Human Cell Glycoproteins
ISEF · 2025
Modeling Bird Flu Mutation Patterns and Cross-Species Transmission Using Sequence Analysis and a Novel Contrastive Learning and Influence-tree Graph Attention Network (CLIGAT)
CWSF · 2026
Preparing for a Future Pandemic: Analyzing Emerging Sequence Variations in Avian Influenza
ISEF · 2015
Analyzing Hemagglutinin Protein Sequences of H3N2 Influenza Viruses to Predict Antigenic Variants
ISEF · 2022
FluVaxAI: A Novel AI-Inspired Regional Flu Vaccine Formulation
ISEF · 2014
Approaching Anti-Viral Therapeutics via Sequence Analysis of Nucleoprotein and Glycoprotein Precursor Genes of Lassa Virus
Closest projects by meaning, across every fair and year in the corpus.